Tiger Brokers

BUZZ-Australia's Althea rises on pharma asset sale, focus on North American operations

Reuters
May 07
BUZZ-Australia's Althea rises on pharma asset sale, focus on North American operations

** Shares of Althea Group Holdings AGH.AX rise 13% to A$0.026, set for strongest trading session since mid-April, if gains hold

** The cannabis products maker to sell its pharmaceutical assets to private firm Tasmanian Botanics for A$1 million ($648,100)

** Says divestment allows co to focus on cannabis-infused beverages market in North America

** Adds that co's unit Peak USA successfully completed inaugural commercial manufacturing run in December 2024, a critical step in scaling U.S. operations

** Around 916,000 shares change hands vs 30-day avg volume of 535,00 shares

** Althea stock down 23.5% YTD, including current session's moves

($1 = 1.5430 Australian dollars)

(Reporting by Nikita Maria Jino in Bengaluru)

((Nikita.Jino@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10